Cell migration inducing hyaluronidase 1 promotes growth and metastasis of papillary thyroid carcinoma

Bioengineered. 2022 May;13(5):11822-11831. doi: 10.1080/21655979.2022.2074110.


Cell migration inducing hyaluronidase 1 (CEMIP) mediates catabolism of hyaluronan, and participates in the cell metastasis, invasion, and motility. Dysregulated CEMIP expression was associated with progression and prognosis of tumors. The role of CEMIP in papillary thyroid carcinoma (PTC) remains unknown. Our study showed that CEMIP was upregulated in both tissues and cells of PTC. Silencing of CEMIP reduced cell proliferation and suppressed migration and invasion of PTC. Protein expression of phosphorylated STAT3 (Signal Transducer And Activator Of Transcription 3) (p-STAT3), AKT (p-AKT) and p65 (p-p65) were decreased by CEMIP silencing in PTC cells. Pyruvate dehydrogenase kinase 4 (PDK4) over-expression attenuated CEMIP silencing-induced decrease in p-STAT3, p-AKT and p-p65. Silencing of CEMIP-induced decrease in cell proliferation and metastasis in PTC were restored by over-expression of STAT3. CEMIP functioned as an oncogenic gene in PTC through PDK4-mediated activation of STAT3/AKT/NF-κB pathway.

Keywords: CEMIP; PDK4; STAT3/AKT/NF-κB; metastasis; papillary thyroid carcinoma.

MeSH terms

  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Humans
  • Hyaluronoglucosaminidase* / genetics
  • Hyaluronoglucosaminidase* / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction / genetics
  • Thyroid Cancer, Papillary / genetics
  • Thyroid Cancer, Papillary / pathology
  • Thyroid Neoplasms* / pathology


  • Proto-Oncogene Proteins c-akt
  • CEMIP protein, human
  • Hyaluronoglucosaminidase

Grant support

The author(s) reported there is no funding associated with the work featured in this article.